Cybin (HELP) Common Equity (2021 - 2025)
Cybin (HELP) posted quarterly Common Equity of $273.9 million for Q4 2025, up 59.29% year-on-year from $172.0 million in Q4 2024, and up 97.08% on a QoQ basis from $139.0 million in Q3 2025.
Cybin (HELP) Common Equity (2021 - 2025) Analysis & Trends
Cybin (HELP) has reported Common Equity for 5 consecutive years, with $273.9 million the latest figure, recorded in Q4 2025.
- Quarterly Common Equity rose 59.29% year-over-year to $273.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $273.9 million (up 59.29% YoY) and the FY2024 annual result came in at $216.6 million, changed N/A from the prior year.
- Common Equity advanced to $273.9 million in Q4 2025 per HELP's latest filing, from $139.0 million in the prior quarter.
- Over the last five years, Common Equity for HELP reached as high as $273.9 million in Q4 2025 and fell as low as $30.5 million in Q1 2023.
- A 5-year average of $113.0 million and a median of $79.0 million in 2021 frame the typical range for Common Equity.
- Annual changes were most pronounced in 2022 — Common Equity tumbled 41.29% — and 2024, when it surged 417.97%.
- Year by year, Common Equity stood at $70.7 million in 2021, then tumbled by 41.29% to $41.5 million in 2022, then soared by 114.58% to $89.0 million in 2023, then soared by 93.14% to $172.0 million in 2024, then surged by 59.29% to $273.9 million in 2025.
- According to Business Quant data, Common Equity over the past three periods registered $273.9 million, $139.0 million, and $151.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 251.12 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -98.34 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 4.76 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 32.36 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 19.36 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 31.42 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 795.79 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.50 Bn |
| 10 | Cybin | 28.04 Mn | 28.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 273.93 Mn |
| Sep 30, 2025 | 139.00 Mn |
| Jun 30, 2025 | 151.76 Mn |
| Dec 31, 2024 | 171.98 Mn |
| Sep 30, 2024 | 186.94 Mn |
| Jun 30, 2024 | 204.60 Mn |
| Mar 31, 2024 | 216.64 Mn |
| Dec 31, 2023 | 89.04 Mn |
| Sep 30, 2023 | 36.09 Mn |
| Jun 30, 2023 | 50.67 Mn |
| Feb 28, 2023 | 30.46 Mn |
| Dec 31, 2022 | 41.49 Mn |
| Sep 30, 2022 | 49.25 Mn |
| Dec 31, 2021 | 70.68 Mn |
| Sep 30, 2021 | 78.96 Mn |
| Jun 30, 2021 | 62.05 Mn |
| Mar 31, 2021 | 68.04 Mn |